Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Evelo Biosciences Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH
Ticker
Exchange
SIC #
Website
Latest Ticker
EVLO
Over the counter
8731
https://evelobio.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Evelo Biosciences Inc
Flagship-backed microbiome biotech Evelo to shut down
- Nov 22nd, 2023 12:00 pm
Horizon Technology Finance Corporation (NASDAQ:HRZN) Q3 2023 Earnings Call Transcript
- Nov 2nd, 2023 12:40 pm
Q3 2023 Horizon Technology Finance Corp Earnings Call
- Nov 2nd, 2023 6:12 am
Evelo (EVLO) Drops 59% on Flunking Psoriasis Drug Study
- Oct 18th, 2023 3:21 pm
Biotech Stock Roundup: ALDX, EVLO Down on Setback, SRRK Offers Updates & More
- Oct 18th, 2023 12:30 pm
Evelo Biosciences Announces Top-Line Results From its Phase 2 Clinical Study with EDP2939 in Moderate Psoriasis
- Oct 17th, 2023 11:00 am
Evelo Biosciences Announces Second Quarter Financial Results and Recent Business Highlights
- Aug 14th, 2023 11:30 am
Evelo Biosciences Closes $25.5 Million Private Placement
- Jul 12th, 2023 11:30 am
Evelo Biosciences Announces $25.5 Million Private Placement
- Jul 10th, 2023 11:30 am
Evelo Biosciences Announces Reverse Stock Split Effective
- Jun 29th, 2023 1:00 pm
What Makes Evelo Biosciences, Inc. (EVLO) a New Buy Stock
- May 17th, 2023 4:00 pm
Flagship Pioneering Launches Metaphore Biotechnologies to Unlock the Therapeutic Potential of Biomimicry
- May 16th, 2023 10:00 am
Evelo Biosciences Insiders Added US$575k Of Stock To Their Holdings \
- May 10th, 2023 12:42 pm
Evelo Biosciences' Atopic Dermatitis Study Cohort Misses Primary Goal Again, Shuts Study, Lays Off More Staff
- Apr 26th, 2023 7:51 pm
Evelo Biosciences Provides Clinical Updates
- Apr 26th, 2023 11:30 am
Scroll